News & Analysis on Clinical Trial Services & Contract Research And Development
High Purity New England: Michael Quesenberry, chief scientific officer
By Jenni Spinner
- Last updated on
Pharma supplier equipment and systems supplier High Purity New England (HPNE) has named industry veteran Michael Quesenberry chief scientific officer. He will spearhead a number of initiatives, including new product development, employee training, and the creation of a new state-of-the-art laboratory and specialty materials and manufacturing workshop.
Before joining HPNE, Quesenberry had conducted process development work at preclinical companies like Avaxia, Xencor, and Werewolf Therapeutics; and larger biotechs such as BMS, Pfizer, Lonza, and Pall Life Sciences. At Pall, Mike started as subject matter expert across the portfolio and finished as certified trainer for all product lines.